Kappa Free Light Chains | List of Frontiers open access articles

Original Research

Published on 11 Oct 2023

Kappa free light chains index in multiple sclerosis very long-term prognosis

in Multiple Sclerosis and Neuroimmunology

Pablo Arroyo-Pereiro
Lydia García-Serrano
Francisco Morandeira
Blanca Urban
Virginia Mas
Mario Framil
Isabel León
Albert Muñoz-Vendrell
Elisabet Matas
Lucía Romero-Pinel

Frontiers in Immunology

doi 10.3389/fimmu.2023.1223514

22,713 views
10 citations

Original Research

Published on 30 Apr 2024

Inter-assay diagnostic accuracy of cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Cathérine Dekeyser
Pieter De Kesel
Melissa Cambron
Ludo Vanopdenbosch
Liesbeth Van Hijfte
Martine Vercammen
Guy Laureys

Frontiers in Immunology

doi 10.3389/fimmu.2024.1385231

5,413 views
13 citations

Brief Research Report

Accepted on 26 Feb 2026

Kappa free light chains in cerebrospinal fluid to detect inflammation - results from a multicentric prospective real-world study

in Multiple Sclerosis and Neuroimmunology

Marie Suesse
Malte Johannes Hannich
Felix Lottermoser
Stefan Gross
Kathrin Budde
Irena Crnkovic-mertens
Margot Thiaucourt
Markus Roser
Franz Felix Konen
Thomas Skripuletz

Frontiers in Immunology

Original Research

Published on 07 Mar 2022

High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis

in Multiple Sclerosis and Neuroimmunology

Jéssica Castillo-Villalba
Sara Gil-Perotín
Raquel Gasque-Rubio
Laura Cubas-Nuñez
Sara Carratalà-Boscà
Carmen Alcalá
Carlos Quintanilla-Bordás
Francisco Pérez-Miralles
Cristina Ferrer
Antonio Cañada Martínez

Frontiers in Immunology

doi 10.3389/fimmu.2022.827738

9,200 views
21 citations

Brief Research Report

Published on 19 Dec 2023

Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis – a multicentre study

in Multiple Sclerosis and Neuroimmunology

Harald Hegen
Klaus Berek
Paola Cavalla
Mikael Christiansen
Andreja Emeršič
Massimiliano Di Filippo
Lorenzo Gaetani
Michaela Hassler
Cyra Leurs
Dejan Milosavljevic

Frontiers in Immunology

doi 10.3389/fimmu.2023.1327947

5,714 views
17 citations

Mini Review

Published on 27 Apr 2022

Biological Markers in Early Multiple Sclerosis: the Paved Way for Radiologically Isolated Syndrome

in Autoimmune and Autoinflammatory Disorders

Manon Rival
Manon Galoppin
Eric Thouvenot

Frontiers in Immunology

doi 10.3389/fimmu.2022.866092

11,188 views
26 citations

Original Research

Published on 25 Mar 2022

Kappa Free Light Chains, Soluble Interleukin-2 Receptor, and Interleukin-6 Help Explore Patients Presenting With Brain White Matter Hyperintensities

in Autoimmune and Autoinflammatory Disorders

Michael Levraut
Cassandre Landes
Lydiane Mondot
Mikael Cohen
Saskia Bresch
Vesna Brglez
Barbara Seitz-Polski
Christine Lebrun-Frenay

Frontiers in Immunology

doi 10.3389/fimmu.2022.864133

4,175 views
10 citations

Articles

Kappa free light chains index in multiple sclerosis very long-term prognosis

Inter-assay diagnostic accuracy of cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis

Kappa free light chains in cerebrospinal fluid to detect inflammation - results from a multicentric prospective real-world study

High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis

Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis – a multicentre study

Biological Markers in Early Multiple Sclerosis: the Paved Way for Radiologically Isolated Syndrome

Kappa Free Light Chains, Soluble Interleukin-2 Receptor, and Interleukin-6 Help Explore Patients Presenting With Brain White Matter Hyperintensities